Alto Neuroscience, Inc. Common Stock (ANRO)
Financing Cash Flow
$165.01M
TTM · Period ending: · USD
ANRO Financing Cash Flow
Latest reported$165.01Mperiod ending
Latest reported$165.01Mperiod ending
ANRO Cash from Financing ($31.69M → $165.01M)
Annual financing cash flow
High-resolution chart · PNG
ANRO financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 60,078,000 | |
| 135,691,000 | |
| 68,130,000 | |
| 43,789,000 | |
| 31,688,000 |